Benign proliferative epithelial disorders of the breast: A review of the epidemiologic evidence

Breast Cancer Research and Treatment

Volumn 110, Issue 3, 2008, Pages 397-409

  Silvera, Stephanie A Navarro ^a   Rohan, Thomas E ^b  

^a MONTCLAIR STATE UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ALCOHOL CONSUMPTION; BENIGN PROLIFERATIVE EPITHELIAL DISORDER; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; BREAST DYSPLASIA; CANCER GROWTH; CANCER INCIDENCE; CIGARETTE SMOKING; DIETARY INTAKE; FIBROCYSTIC BREAST DISEASE; HISTOPATHOLOGY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; MENARCHE; MENOPAUSE; MORBIDITY; NULLIPARA; OCCULT CANCER; PARITY; POSTMENOPAUSE; PREVALENCE; PRIMIGRAVIDA; PRIORITY JOURNAL; REPRODUCTION; REVIEW; RISK FACTOR;

ANIMALS; BREAST DISEASES; FEMALE; HUMANS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 46949094599     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9740-3     Document Type: Review

References (68)

1. Rohan TE, Kandel RA (2002) Breast. In: Franco EL, Rohan TE (eds) Cancer precursors: epidemiology, detection, and prevention. Springer-Verlag, New York, 232-248
2. Soini I, Aine R, Lauslahti K, Hakama M (1981) Independent risk factors of benign and malignant breast lesions. Am J Epidemiol 114:507-514
3. Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272-278
4. Miller AB, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ, Heppner GH (1993) Xenograph model of progressive human proliferative breast disease. J Natl Cancer Inst 85:1725-1732
5. Davies BR, Platt-Higgins AM, Schmidt G Rudland PS (1999) Development of hyperplasias, preneoplasias, and mammary tumors in mmtv-c-erbb-2 and mmtv-tffα transgenic rats. Am J Pathol 155:303-314
6. Li Y, Hively WP, Varmus HE (2000) Use of mmtv-wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19:1002-1009
7. Schnitt SJ (2003) Benign breast disease and breast cancer risk. Am J Surg Pathol 27:836-841
8. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton III LJ and Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229-237
9. Worsham MJ, Abrams J, Raju U, Kapke A, Lu M, Cheng J, Mott D, Wolman SR (2007) Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 13:115-121
10. Marshall LM, Hunter DJ, Connolly JL, Schnitt SK, Byrne C, London SJ, Colditz G (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297-301
11. Wang DY, Fentiman IS (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 6:5-36
12. Rohan TE, Hartwick W, Miller AB, Kandel RA (1998) Immunohistochemical detection of c-erbb-2 and p53 proteins in benign breast disease and breast cancer risk. J Natl Cancer Inst 90:1262-1269
13. Franz VK, Pickren JW, Melcher GW, Auchincloss H Jr (1951) Incidence of chronic cystic disease in so-called normal breasts. Cancer 4:762-783
14. Sloss PT, Bennett WA, Clagett OT (1957) Incidence in normal breasts of features associated with chronic cystic mastitis. Am J Pathol 33:1181-1191
15. Sandison AT (1962) An autopsy study of the adult human breast. US GPO, Washington, DC
16. Humphrey LJ, Swerdlow M (1966) Histologic changes in clinically normal breasts at postmortem examination. Arch Surg 92:192-193
17. Kramer WM, Rush Jr BF (1973) Mammary duct proliferation in the elderly. A histopathologic study. Cancer 31:130-137
18. Sasano N, Tateno H, Stemmerman GN (1978) Volume and hyperplastic lesions of breasts of japanese women in hawaii and japan. Prev Med 7:196-204
19. Nielson M, Jenson J, Anderson J (1984) Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women. Cancer 54:612-615
20. Alpers CE, Wellings SR (1985) The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 16:796-807
21. Bhathal PS, Brown RW, Lesueur GC, Russell IS (1985) Frequency of benign and malignant breast lesions in 207 consecutive autopsies in australian women. Br J Cancer 51:271-278
22. Nielson M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA (1987) Breast cancer and atypia among young and middle aged women: A study of 110 medicolegal autopsies. Br J Cancer 56:814-819
23. Sarnelli R, Squartini F (1991) Fibrocstic condition and "at risk" lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol 18:271-279
24. Ory H, Cole P, MacMahon B, Hoover R (1976) Oral contraeptive and reduced risk of benign breast disease. N Engl J Med 249:419-422
25. Cole P, Elwood JM, Kaplan SD (1978) Incidence rates and risk of factors of benign breast neoplasms. Am J Epidemiol 108:112-120
26. Brinton LA, Vessey MP, Flavel R, Yeates D (1981) Risk factors for benign breast disease. Am J Epidemiol 113:203-214
27. Fleming NT, Armstrong BK, Sheiner HJ (1982) The comparative epidemiology of benign breast lumps and breast cancer in western australia. Int J Cancer 30:147-152
28. Heinemann K, Thiel C, Mohner S, Lewis MA, Raff T, Kuhl-Habich D, Heinemann LAJ (2003) Benign gynecological tumors: Estimate incidence results of the german gohort study on women's health. Eur J Obstet Gynecol Reprod Biol 107:78-80
29. Cook MG, Rohan TE (1985) The patho-epidemiology of benign proliferative epithelial disorders of the female breast. J Path 146:1-15
30. Lance LL (1981) Risk factors for benign breast disease. Am J Epidemiol 114:606-607
31. Parazzini F, La Vecchia C, Franceschi S, Decarli A, Gallus G, Regallo M, Liberati A, Tognoni G (1991) Risk factors for pathologically confirmed benign breast disease. Am J Epidemiol 120:115-122
32. Parazzini F, Perraroni M, La Vecchia C, Baron JA, Levi F, Franceschi S, Decarli A (1991) Smoking habits and risk of benign breast disease. Int J Epidemiol 20:430-434
33. Berkowitz GS, Kelsey JL, LiVolsi VA, Holford TR, Merino MJ, Ort S, O'Connor TZ, White C (1985) Risk factors for fibrocystic breast disease and its histopathologic components. J Natl Cancer Inst 75:43-50
34. Pastides H, Kelsey JL, Holford TR, LiVolsi VA (1985) An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia. Am J Epidemiol 121:440-447
35. Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NL, Kopans DB, Meyer JE (1989) Histologic and mammographic specificity of risk factors for benign breast disease. Cancer 64:653-657
36. Rohan TE, Cook MG (1989) Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women. Int J Cancer 43:631-636
37. Rohan TE, Cook MG, Baron JA (1989) Cigarette smoking and benign proliferative epithelial disorders of the breast in women: A case-control study. J Epidemiol Community Health 43:362-368
38. Ingram DM, Nottage E, Ng S, Sparrow L, Roberts A, Willcox D (1989) Obesity and breast disease. The role of the female sex hormone. Cancer 64:1049-1053
39. Ingram DM, Nottage E, Roberts T (1991) The role of diet in the development of breast cancer: A case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. Br J Cancer 64:187-191
40. London SJ, Stein EA, Henderson IC, Stampfer MJ, Wood WC, Remine S, Dmochowski JR, Robert NJ, Willett WC (1992) Carotenoids, retinol, and vitamin e and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 3:503-512
41. Minami Y, Ohuchi N, Taeda y, Fukao A, Hisamichi S (1998) Risk factors for benign breast disease according to histopathological type: Comparisons with risk factors for breast disease. Jpn J Cancer Res 89:116-123
42. Hsieh CC, Walker AM, Trapido EJ, Crosson AW, MacMahon B (1984) Age at first birth and breast atypia. Int J Cancer 33:309-312
43. Rohan TE, L'Abbe KA Cook MG (1992) Oral contraceptives and risk of benign proliferative epithelial disorders of the breast. Int J Cancer 50:891-894
44. LiVolsi VA, Stadel BV, Kelsey JL, Holford TR, White C (1978) Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia. N Engl J Med 299:381-385
45. Pastides H, Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Goldenberg IS (1983) Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology. J Natl Cancer Inst 71:5-9
46. Berkowitz GS, Kelsey JL, Merino MJ, Holford TR, Hildreth NG, Ort S, O'Connor TZ, White C (1984) Exogenous hormone use and fibrocystic breast disease by histopathologic component. Int J Cancer 34:443-449
47. Rohan TE, Miller AB (1999) Hormone replacement therapy and risk of benign proliferative epithelial disorders of the breast. Eur J Epidemiol 8:123-130
48. Rohan TE, Cook MG, Potter JD, McMichael AJ (1990) A case-control study of diet and benign proliferative epithelial disorders of the breast. Cancer Res 50:3176-3181
49. London SJ, Sacks FM, Stampfer MJ, Henderson AC, Maclure M, Tomita A, Wood WC, Remine S, Robert NJ, Dmochowski JR, Willett WC (1993) Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst 85:785-793
50. Baghurst PA, Rohan TE (1995) Dietary fiber and risk of benign proliferative epithelial disorders of the breast. Int J Cancer 63:481-485
51. Lubin F, Wax Y, Ron E, Black M, Chetrit A, Rosen N, Alfandary E, Modan B (1989) Nutritional factors associated with benign breast disease etiology: A case-control study. Am J Clin Nutr 50:551-556
52. Friedenreich CM, Rohan TE (1994) Recreational physical activity and risk of benign proliferative epithelial disorders of the breast in women. Eur J Cancer Prev 3:465-471
53. Wu C, Ray RM, Lin MG, Neilann DLG, Korner NK, Nelson ZC, Lampe JW, Hu YW, Shannon J, Stalsberg H, Li W, Fitzgibbons PL, Porter P, Patterson RE, Satia JA, Thomas DB (2004) A case-control study of risk factors for fibrocystic breast conditions. Shanghai nutrition and breast disease study, china, 1995-2000. Am J Epidemiol 160:945-960
54. Friedenreich CM, Bryant HE, Alexander F, Hugh J, Danyluk J, Page DL (2000) Risk factors for benign proliferative breast disease. Int J Epidemiol 29:637-644
55. Rohan TE, Jain M, Miller AB (1998) A case-cohort study of diet and risk of benign proliferative epithelial disorders of the breast (canada). Cancer Causes Control 9:19-27
56. Rohan TE, Miller AB (1999) A cohort study of oral contraceptive use and risk of benign breast disease. Int J Cancer 82:191-196
57. Rohan TE (1999) Cigarette smoking and risk of benign proliferative epithelial disorders of the breast. Eur J Epidemiol 15:529-535
58. Rohan TE, Jain M, Miller AB (1998) Alcohol consumption and risk of benign proliferative epithelial disorders of the breast: A case-cohort study. Public Health Nutr 1:139-145
59. Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs TW, Baer HJ, Willett WC, Colditz G (2004) A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev 13:1106-1113
60. Cui Y, Page DL, Chlebowski RT, Beresford SA, Hendrix SL, Lane DS, Rohan TE (2007) Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast. Int J Cancer online advance of print, http://www3.interscience.wiley.com/cgi-bin/fulltext/114274175/HTMLSTART
61. Cui Y, Page DL, Chlebowski RT, Hsia J, Hubbell FA, Johnson KC, Rohan TE (2007) Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the women's health initiative. Cancer Causes Control 18:431-438
62. Hislop TG, Band PR, Deschamps M, Ng V, Coldman AJ, Worth AJ, Labo T (1990) Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 131:263-270
63. Hankinson SE, Hunter DJ (2002) Breast cancer. In: Adami HO, Hunter DJ, Tricholopoulos D (eds) Textbook of cancer epidemiology. Oxford, Oxford University Press, pp 301-339
64. World Cancer Research Fund and American Institute for Cancer Research (1997) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC
65. IARC (2002) Handbooks on cancer prevention, weight control and physical activity. Lyon, IARC Press
66. . Huang Z, Hankinson SE, Colditz G, Stampfer MJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC (1997) Dual effects of weight and weight gain on breast cancer. JAMA 278:1407-1411
67. Hunter DJ, Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15:110-132
68. Singletary SE (2003) Rating the risk factors for breast cancer. Ann Surg 237:474-482